FOCAL ONSET SEIZURES
Clinical trials for FOCAL ONSET SEIZURES explained in plain language.
Never miss a new study
Get alerted when new FOCAL ONSET SEIZURES trials appear
Sign up with your email to follow new studies for FOCAL ONSET SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Hard-to-Control seizures
Disease control CompletedThis study tested an experimental drug called XEN1101 in 380 adults with focal-onset seizures that were not fully controlled by other medications. Participants took XEN1101 or a placebo alongside their usual seizure drugs. The goal was to see if XEN1101 could safely reduce seizur…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug shows promise for Tough-to-Treat seizures
Symptom relief CompletedThis study tested an experimental drug called RAP-219 in 30 adults with refractory focal epilepsy, a type of epilepsy that doesn't respond well to standard treatments. All participants had a brain implant to monitor seizures. The goal was to see if RAP-219 could safely reduce the…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE2 • Sponsor: Rapport Therapeutics Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC